MeJeTo Mid-West Japan Hereditary Tumor Cohort
MeJeTo is a research project in genomics and personalized medicine. It is a large hereditary tumor
cohort that has collected DNA, clinical data, and epidemiological data from 51 institutions in
Japan.
MeJeTo provides a Japan-wide resource for further breakthroughs in cancer prevention, diagnosis, and
treatment.
Participants
Data from Japanese individuals who have undergone genetic testing. Pathogenic variants and VUS are included, ranging from high to moderate penetrance genes.
Biobank
DNA, tissue samples, genomic data, family history, and epidemiological data are available.
Collaborators
51 institutions across Japan are collaborating and conducting joint research.
Publications
List of research accomplishments including conference presentations and published papers.